Parametrica Management LTD Alkermes Plc. Transaction History

Parametrica Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$28.4 - $36.49 $445,454 - $572,345	-15,685 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$27.94 - $44.61 $249,867 - $398,947	8,943 Added 132.65%	15,685 $463,000
Q3 2018 Nov 06, 2018	BUY	$38.6 - $46.12 $260,241 - $310,941	6,742 New	6,742 $286,000

358

180M

522K

463K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.11B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.